Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Poster Exhibitions

Wednesday lulv io

-. - -. ----Y I --y --

WePeC6229 Studies on acute primary HIV infection with HIV-1
subtype C infection in India
R S Paraniape', SM Mehendale', M R Thakar',
R G Brahme', B M Mahajan', SS Kulkarni',
S P Tripathy', R C Bollinger2
(lndia; 2United States)
WePeC623o Evaluation of different techniques for the
estimation of the levels of CD4 cells in Lagos
Nigeria
R Audu, I Onyewuche, 0 Funsho-Adebayo,
C Oparugo, D / Onwujekwe, CC Onubogu,
IA Adedoyin, E 0 Idigbe (Nigeria)
WePeC6231 Effective antiretroviral therapy reduces
degradation of tryptophan in patients with HIV-1
infection
R Zangerle, M Sarcletti, G Quirchmair, B Widner,
G Neurauter, D Fuchs (Austria)
WePeC6232 Factors associated with normal CD4:CD8 ratios in
HIV infected persons
P Menezes, S Napravnik, W C Miller, J J] Eron ]r
(United States)
WePeC6233 Humoral response to hepatitis B vaccination and
its relationship with T CD4+ cell subsets in HIV-1
infected subjects
A P R Veiga, S Komninakis, N Orii, R Stellin,
J Casseb, A J S Duarte (Brazil)
WePeC6234 Characterization of HIV-1 genome from a patient
who is western blot weak positive and HIV
genome undetectable by PCR for 18 months
M K Kondo TS Shima, KS Sudo, M N Nishizawa,
S I Iwamuro, TO Okabe, M I/ Imai (apan)
WePeC6235 A synergistic effect of human immunodeficiency
virus and cytomegalovirus infection/reactivation
on response to HAART and plasma CD8/CD38 but
not CD4 cell populations in patients with primary
human immunodeficiency virus Infection
L Goh', M Bernard2, F Lampe', G janossy,
D Cooper3, P Cunningham3, I Andersson4,
S Kinloch', H Mcdade', L Perrin2, A Capt5
'United Kingdom; 2Switzerland; 3Australia;
(4Sweden; 5United States)
WePeC6236 Effect of pregnancy on HIV disease progression
and survival from seroconversion among women
in rural Uganda
L V F Van der Paal, R Muwonge, B Mayanja,
JA G Whitworth (Uganda)
WePeC6237 Effect of pregnancy on maternal HIV disease
progression in the Women and Infants
Transmission Study (WITS)
R C Hershow', H Minkoff, R Tuomala', H Watts',
M Frederick', C Zorrilla2, H HammilP', J Pitt'
(United States; 2United States Territory)
WePeC6238 Gastrointestinal infections in AIDS patients
D P Pandit S Raina, S Sangle, R Bharadwaj
(India)
WePeC6239 Effect of HSVi and 2 on HIV viral load after HIV
seroconversion
A M Rompalo, Astemborksi, I M Zenilman,
T C Quinn, D Vlahav (United States)
WePeC624o Determinants of HIV Seroprevalence Rates in
Developing Countries
P K D Drain, K K H Holmes, ] PH Hughes
(United States)
WePeC6241 Low socio-economic status is associated with
higher rates of death in the era of highly active
anti-retroviral therapy
W McFarland S Chen, L Hsu, S K Schwarcz,

M H Katz (United States)
WePeC6242 Psycho-social aspects of AIDS Epidemic in India
S Singh V Balooni, S Singhal, N Singh (India)

WePeC6243 HIV/AIDS: Impediments to behaviour change
J V Summerton (South Africa)
WePeC6244 Longitudinal relationship between depression
and CD4 cell count decline in a cohort of HIVseropositive women
JA Cook, M H Cohen, D D Grey, J Burke,
J Richardson, T E Wilson, R Greenblatt, M Young,
A Gurtman (United States)
WePeC6245 Human values as an epidemiological paradigm to
assess HIV/AIDS prevention, care and treatment
intervention
V V Nair V R C Hernandez (United States)
WePeC6246 Homozygosity at class I HLA loci is
disadvantageous in controlling early HIV-1
viremia and subsequent disease progression in
the multicenter AIDS cohort study
R A Kaslow J Tang, A Penman-Aguilar, S Tang,
J Mellors, A Munoz, M Carrington (United States)
WePeC6247 What distinguishes Australian PLWHA not
receiving combination antiviral treatment?
G Prestage, A Grulich, P Rawstorne, A Song,
J Grierson (Australia)
WePeC6248 Surveillance for adherence to antiretroviral
therapies and associated factors: Results from a
multistate interview project in the US
PS Sullivan G V Nakamura, M L Campsmith
(United States)
WePeC6249 Antiretroviral therapy and AIDS mortality in the
urban poor: the REACH cohort study
AR Moss, S Perry, E Riley, D Bangsberg
(United States)
WePeC625o Readiness to use antiretrovirals by HIV-infected
patients in Trinidad and Tobago
N Jack', H Smith', J DaniePl', M Telfer-Baptiste',
K Fergusson', A Gonzalez', F Cleghorn2,
C Bartholomew' (Trinidad and Tobago; 2United
States)
WePeC6251 Skeletal muscle damage during HIV disease:
frequency, possible causes, clinical and
laboratory features, and consequences
R Manfredi, L Calza, F Chiodo (Italy)
WePeC6252 Effects of different protease inhibitors on
apolipoprotein B and plasma lipid profile of HIVinfected patients
P Domingo J A Arroyo, M A Sambeat,
MA Sambeat, A Perez, J Ordonez, J Cadafalch,
M Fuster, M Gurgui, G Vasquez (Spain)
WePeC6253 Validity of body image perception in women with
H IV.
G Guaraldi', G Orlando', R Murri', E Orlandi',
R Covezzi', G Nardini, B Beghetto', A Bedini',
R Esposito', A Wu2 ('taly; 2United States)
WePeC6254 Increasing rate of cardiac procedures among HIVpositive individuals on antiretroviral therapy from
1993-2001
P KA Braitstein, B Yip, S G Montaner, A Levy,
I Joseph, FM Kiely, M V O'Shaughnessy, R S Hogg
(Venezuela)
WePeC6255 Factors associated to the impact of lipodystrophy
on quality of life in HIV--infected patients
JBlanch, A Rousaud, E Martinez, E De Lazzari,
I M Peri, A Milinkovic, I B Perez-Cuevas,
I L Blanco, I M Gatell (Spain)
WePeC6256 The lean body mass in HIV infected patients
G Tsekes D Paraskeva, G Douskas, N Mangafas,
M Chini, M Boboli, D Chalkiadaki, E Georgiou,
M C Lazanas (Greece)

WePeC6257 A new proposal to deal with facial lipodistrophy
V Vasques M Garcia, E Cortes (Brazil)
XIV International AIDS Conference BARCELONA - JULY 7-12

Wednesday

173